Turner syndrome and metabolic derangements: Another example of fetal programming

Early Human Development

Volumn 88, Issue 2, 2012, Pages 99-102

  Baldin, Alexandre Duarte ^a   Siviero Miachon, Adriana Aparecida ^b   Fabbri, Tatiana ^b   De Lemos Marini, Sofia Helena Valente ^a   Spinola Castro, Angela Maria ^b   Baptista, Maria Tereza Matias ^a   D'Souza Li, Lilia Freire Rodrigues ^a   Morcillo, André Moreno ^a   Maciel Guerra, Andrea Trevas ^a   Guerra Junior, Gil ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Birth weight; Body mass index; Fetal programming; Length weight; Turner syndrome

Indexed keywords

GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; SCHOOL CHILD; SMALL FOR DATE INFANT; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME;

ADOLESCENT; ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DEVELOPMENT; HUMANS; INSULIN; INSULIN RESISTANCE; METABOLIC DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TRIGLYCERIDES; TURNER SYNDROME; YOUNG ADULT;

EID: 84856958514     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.07.014     Document Type: Article

References (34)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Reilly J.J., Methven E., McDowell Z.C., Hacking B., Alexander D., Stewart L., et al. Health consequences of obesity. Arch Dis Child 2003, 88:748-752.
3. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity and programming. Physiol Rev 2005, 85:571-663.
4. Ismail-Beigi F., Catalano P.M., Hanson R.W. Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult. Am J Physiol Endocrinol Metab 2006, 291:439-440.
5. Druet C., Ong K.K. Early childhood predictors of adult body composition. Best Pract Res Clin Endocrinol Metab 2008, 22:489-502.
6. Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008, 32:213-218.
7. Simmons R. Perinatal programming of obesity. Semin Perinatol 2008, 32:371-374.
8. Srinivasan M., Patel M.S. Metabolic programming in the immediate postnatal period. Trends Endocrinol Metab 2008, 19:146-152.
9. Patel M.S., Srinivasan M., Laychock S.G. Metabolic programming: role of nutrition in the immediate postnatal life. J Inherit Metab Dis 2009, 32:218-228.
10. Tamashiro K.L., Moran T.H. Perinatal environment and its influences on metabolic programming of offspring. Physiol Behav 2010, 100:560-566.
11. Lucas A. Programming by early nutrition in man. Ciba Found Symp 1991, 156:38-50.
12. Barker D.J. The fetal and infant origins of disease. Eur J Clin Invest 1995, 25:457-463.
13. Blackett P.R., Rundle A.C., Blethen S.L. Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy. Int J Obes Relat Metab Disord 2000, 24:232-235.
14. Van P.L., Bakalov V.K., Bondy C.A. Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J Clin Endocrinol Metab 2006, 91:2867-2870.
15. Mazzanti L., Bergamaschi R., Castiglioni L., Zappulla F., Pirazzoli P., Cicognani A. Turner syndrome, insulin sensitivity and growth hormone treatment. Horm Res 2005, 64:51-57.
16. Shoemaker M.J., Swerdlow A.J., Higgins C.D., Wright A.F., Jacobs P.A. United Kingdom Clinical Cytogenetics Group. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab 2008, 93:4735-4742.
17. Wisniewski A., Milde K., Stupnicki R., Szufladowicz-Wozniak J. Weight deficit at birth and Turner's syndrome. J Pediatr Endocrinol Metab 2007, 20:607-613.
18. Even L., Cohen A., Marbach N., Brand M., Kauli R., Sippell W., et al. Longitudinal analysis of growth over the first 3years of life in Turner's syndrome. J Pediatr 2000, 137:460-464.
19. Davenport M.L., Punyasavatsut N., Stewart P.W., Gunther D.F., Sävendahl L., Sybert V.P. Growth failure in early life: an important manifestation of Turner syndrome. Horm Res 2002, 57:157-164.
20. Kurtoǧlu S., Hatipoǧlu N., Mazi{dotless}ci{dotless}oǧlu M., Kendirici M., Keskin M., Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Cli Res Pediatr Endocrinol 2010, 2:100-106.
21. Varvarigou A.A. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J Pediatr Endocrinol Metabol 2010, 23:215-224.
22. Lee P.A., Chernausek S.D., Hokken-Koelega A.C., Czernichow P. International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 2003, 111:1253-1261.
23. Van Pareren Y.K., Muinck Keizer-Schrama S.M.P.F., Stijnen T., Sas T.C.J., Drop S.L.S. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 2002, 87:5442-5448. the Dutch Group on growth hormone.
24. Bannink E.M.N., Van der Palen R.L.F., Mulder P.G.H., Muinck Keizer-Schrama S.M.P.F. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences. Horm Res 2009, 71:343-349.
25. Gravholt C.H., Hjerrild B.E., Mosekilde L., Hansen T.K., Rasmussen L.M., Frystyk J., et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 2006, 155:583-592.
26. Gravholt C.H., Naeraa R.W., Brixen K., Kastrup K.W., Mosekilde L. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 2002, 110:889-896.
27. Ekelund U., Ong K.K., Linné Y., Neovius M., Brage S., Dunger D.B., et al. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2007, 92:98-103.
28. Pilgaard K., Færch K., Carstensen B., Poulsen P., Pisinger C., Pendersen O., et al. Low birth weight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia 2010, 53:2526-2530.
29. Fabricius-Bjerre S., Jensen R.B., Færch K., Larsen T., Mφlgaard C., Michaelsen F., et al. Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence. PLoS One 2011, 6:e-20595.
30. Harder T., Rake A., Rohde W., Doerner G., Plagemann A. Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats. Endocr Regul 1999, 33:25-31.
31. Stoffers D.A., Desai B.M., De Leon D.D., Simmons R.A. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 2003, 52:734-740.
32. Vielwerth S.E., Jensen R.B., Larsen T., Holst K.K., Mφlgaard C., Greisen G., et al. The effect of birth weight upon insulin resistance and associated cardiovascular risk factors in adolescence is not explained by fetal growth velocity in the third trimester as measured by repeated ultrasound fetometry. Diabetologia 2008, 51:1483-1492.
33. FitzSimmons J., Fantel A., Shepard T.H. Growth parameters in mid-trimester Turner syndrome. Early Hum Dev 1994, 38:121-129.
34. Owen C.G., Martin R.M., Whincup P.H., Smith G.D., Cook D.G. Does breast feeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr 2006, 84:1043-1054.